These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7069423)

  • 21. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system.
    Mann DM
    Mech Ageing Dev; 1983 Sep; 23(1):73-94. PubMed ID: 6228698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plaques, tangles and Alzheimer's disease.
    Tomlinson BE
    Psychol Med; 1982 Aug; 12(3):449-59. PubMed ID: 7134306
    [No Abstract]   [Full Text] [Related]  

  • 23. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
    Singh S
    Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe atrophy of amygdala and hippocampus in both Alzheimer's disease and multi-infarct dementia.
    Matsuzawa T; Hishinuma T; Matsui H; Meguro K; Ueda M; Kinomura S; Yamada K
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):23-5. PubMed ID: 2103656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuropathology of aminergic nuclei in Alzheimer's disease.
    Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
    Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
    Chan-Palay V; Asan E
    J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of nLC neurons.
    Tanner CM
    Neurology; 1983 Apr; 33(4):524. PubMed ID: 6682205
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of neuropathological and neurochemical correlates of Alzheimer's disease.
    Perry EK; Perry RH
    Dan Med Bull; 1985 Feb; 32 Suppl 1():27-34. PubMed ID: 2859148
    [No Abstract]   [Full Text] [Related]  

  • 30. The nucleus basalis of Meynert in multi-infarct (vascular) dementia.
    Mann DM; Yates PO; Marcyniuk B
    Acta Neuropathol; 1986; 71(3-4):332-7. PubMed ID: 3799146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional consequences of locus coeruleus degeneration in Alzheimer's disease.
    Weinshenker D
    Curr Alzheimer Res; 2008 Jun; 5(3):342-5. PubMed ID: 18537547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
    Wilcock GK; Esiri MM; Bowen DM; Hughes AO
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dogs with canine counterpart of Alzheimer's disease lose noradrenergic neurons.
    Insua D; Suárez ML; Santamarina G; Sarasa M; Pesini P
    Neurobiol Aging; 2010 Apr; 31(4):625-35. PubMed ID: 18573571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hop bitter acids containing a β-carbonyl moiety prevent inflammation-induced cognitive decline via the vagus nerve and noradrenergic system.
    Ano Y; Ohya R; Yamazaki T; Takahashi C; Taniguchi Y; Kondo K; Takashima A; Uchida K; Nakayama H
    Sci Rep; 2020 Nov; 10(1):20028. PubMed ID: 33208787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemistry of senile dementia].
    Kaneko Z; Nishimura T
    Nihon Rinsho; 1976 Sep; 34(9):2719-25. PubMed ID: 1033309
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 37. [Increased activity of stress-regulating systems in Alzheimer disease].
    Hoogendijk WJ; Meynen G; Feenstra MG; Eikelenboom P; Kamphorst W; Swaab DF
    Tijdschr Gerontol Geriatr; 2001 Feb; 32(1):17-23. PubMed ID: 11293840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease.
    Miller MA; Kolb PE; Leverenz JB; Peskind ER; Raskind MA
    J Neurochem; 1999 Nov; 73(5):2028-36. PubMed ID: 10537062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.
    Elrod R; Peskind ER; DiGiacomo L; Brodkin KI; Veith RC; Raskind MA
    Am J Psychiatry; 1997 Jan; 154(1):25-30. PubMed ID: 8988954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
    Förstl H; Levy R; Burns A; Luthert P; Cairns N
    Pharmacopsychiatry; 1994 Jan; 27(1):11-5. PubMed ID: 8159776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.